6: Annex 1 – Are you ready for implementation of the new Annex?
PharmaLex Talks6 Apr 2022

6: Annex 1 – Are you ready for implementation of the new Annex?

Some major changes have been outlined in the EU Annex 1 Revision. Listen to PharmaLex expert Patrick Nieuwenhuizen on how the industry can implement the new Annex 1.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(37)

29: Exploring the interactions between validation and technology transfer

29: Exploring the interactions between validation and technology transfer

Synopsis: In this podcast, Gerardo Gomez talks about the interactions between validation and technology transfer, considering the views and expectations of the regulators. As Gerardo explains, technol...

24 Jan 202413min

28: Early access programs: What they are and how to plan for them

28: Early access programs: What they are and how to plan for them

Synopsis: Early access programs are designed to allow patients suffering from a life-threatening unmet medical need or disease to be given promising treatments that have not yet received marketing app...

5 Dec 202315min

27: Assessing gaps and achieving compliance with Annex 1

27: Assessing gaps and achieving compliance with Annex 1

Bio Patrick Nieuwenhuizen Quality professional with a Microbiology & Sterile Manufacturing background with over 25 years’ experience in the Pharmaceutical Industry. Worked for several global Pharmace...

28 Nov 202315min

26: Navigating the Process of Technology Transfer

26: Navigating the Process of Technology Transfer

Synopsis: Technology transfer involves two main types: scale-up and transfer to a different site. Scale-up technology transfer involves moving a technology or process from a laboratory or pilot-scale ...

14 Nov 202318min

25: Scaling Patient Safety through Innovation

25: Scaling Patient Safety through Innovation

Bio: Michael Braun-Boghos Michael has been working in medicinal product safety for the last three decades. He spent 13 years at the European PV headquarters of Fujisawa, which later became Astellas, ...

25 Sep 202316min

24: Why Early Phase Modeling is Key to Reimbursement and Patient Access

24: Why Early Phase Modeling is Key to Reimbursement and Patient Access

Market access can be a big hurdle for companies to overcome and might require a different approach to the process of gathering evidence to support reimbursement discussions. Early phase modeling can h...

12 Sep 202311min

23: The Unique and Complex World of Combination Products

23: The Unique and Complex World of Combination Products

Combination products offer unique advantages in terms of delivering improved therapeutic outcomes or enhanced patient convenience. Typically, combination products are understood to be a drug-device or...

31 Aug 202310min

22: Avoiding Pitfalls with your Product Development Strategy

22: Avoiding Pitfalls with your Product Development Strategy

Companies often fall into common traps in early-stage product development. These range from interactions with the regulators to their ability to manufacture their product. Forward planning is crucial,...

2 Aug 202312min

Populärt inom Politik & nyheter

aftonbladet-krim
svenska-fall
motiv
p3-krim
flashback-forever
aftonbladet-daily
politiken
rss-sanning-konsekvens
rss-krimreportrarna
rss-flodet
rss-vad-fan-hande
rss-frandfors-horna
svd-ledarredaktionen
rss-aftonbladet-krim
grans
krimmagasinet
spar
dagens-eko
rss-krimstad
blenda-2